The Veterinary Pain Management Market is projected to reach USD 1.66 Billion by 2023 from USD 1.13 Billion in 2018, at a CAGR of 8.0% during the forecast period.

The global veterinary pain management drugs market is a consolidated market, and the top three pharmaceutical companies account for a large share of the global market. Boehringer Ingelheim (Germany), Zoetis (US), Elanco (US), dominated the veterinary pain management drugs market in 2017.

Boehringer Ingelheim

Boehringer Ingelheim held the largest share of global veterinary pain management drugs market in 2017. The company has a strong portfolio of pharmaceutical products that focus on the treatment of chronic diseases in companion animals. For instance, it manufactures and markets Metacam, one of the best-selling pain management drugs used in companion animals to cure osteoarthritis. To sustain its leading position in the market, the company adopted several growth strategies such as expansions, agreements, and partnerships. For example, in 2016, the company opened its new R&D facility at the Iowa State University Research Park in Ames (US).

Zoetis

Zoetis held the second position in the global veterinary pain management drugs market in 2017. It offers widely adopted pain management drugs for companion animals such as cats, dogs, and horses. It is the manufacturer and supplier of Rimadyl, one the best-selling pain management drug brand for dogs. The company focuses on investing in R&D activities in order to maintain and enhance its position in the market. In 2016, the company invested USD 376 million in R&D, which accounts for 8% of its total revenue. Zoetis also focuses on expansions and mergers & acquisitions to improve its product offerings and production capabilities. For example, in 2015, Zoetis established a manufacturing facility in Lincoln, US, to improve production capabilities for animal health products and offer a wider range of animal health products to veterinarians, livestock producers, and pet owners.

In-Case You Need More Detailed Info. on This Study, Feel FREE to Contact Our Research Experts, Today..!

Elanco

Elanco held the third position in veterinary pain management drugs market. Elanco has a vast geographical presence in all major markets. It has offices and research centers at multiple locations within the Americas, Europe, the Middle East and Africa, and Asia Pacific. Elanco primarily pursues the strategy of product launches to increase its share in the veterinary pain management market for example, the company launched Galliprant and Onisor in 2017 & 2016 respectively. The company also adopts inorganic growth strategies such as acquisitions and collaborations to improve its position in the market, like the acquisition of Novartis Animal Health in 2015.

The global veterinary pain management market is consolidated in nature with the top three players, namely, Boehringer Ingelheim (Germany), Zoetis (US), and Elanco (US) accounting for ~65% of the market share in 2017. The other players in this market include Merck Animal Health (US), Chanelle (Ireland), Vetoquinol (France), Bayer (Germany), Norbrook (Ireland), Ceva Santé Animale (France), K-Laser (US), Assisi (US), and Dechra Pharmaceuticals (UK) who collectively accounted for a share of ~35% of the market in 2017.

Target Audience:

• Healthcare institutions (hospitals, medical schools, and outpatient clinics)
• Market research and consulting firms
• Venture capitalists and investors
• Research & development companies
• Veterinary pain management manufacturers and distributors

You Can Also Request to Get 10% FREE Customization on This Report

Scope of the Report

The research report categorizes the global veterinary pain management market into the following segments and sub segments:

• By Products:
  • Drugs
    • By Type
      • NSAIDs
      • Opioids
      • Local Anesthetics
      • Alpha-2 Agonists
      • Disease-modifying Osteoarthritis Agents
      • Other Drugs
    • By Route of Administration
      • Oral
      • Parenteral
      • Topical
  • Devices
    • Laser Therapy Devices
    • Electromagnetic Therapy Devices
• By Application:
  • Joint Pain
    • Osteoarthritis
    • Musculoskeletal
  • Postoperative Pain
  • Cancer
  • Other Applications
• By Animal Type:
  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Other Companion Animals
  • Livestock
    • Cattle
    • Swine
    • Other Livestock
• By Distribution Channel:
  • Hospitals & Clinics
  • Pharmacy
• By Region:
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East and Africa